[Clinical treatment pathways: successful due to standardization. Better cooperation, clear responsibilitties, cost analysis and more quality].
Roeder
N
N
DRG-Research-Group, Medizincontrolling des Klinischen Vorstandes, Universitätsklinikum Münster.
D003362:Cost-Benefit Analysis / Q000592:standards; D019091:Critical Pathways / Q000191:economics / Q000592:standards*; D005245:Fee Schedules / Q000592:standards; D018588:Fee-for-Service Plans / Q000191:economics*; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D011785:Quality Assurance, Health Care / Q000191:economics / Q000592:standards*; D014570:Urologic Diseases / Q000191:economics* / Q000601:surgery